Hagen Brett R
CIK 0001681782 Name as filed on the most recent filing
Filed as Hagen Brett R (39)
56 transaction lines · from 39 filings · filed 2021-02-18 to 2026-03-23 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
56 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-20 |
Kalaris Therapeutics, Inc. KLRS |
S, Open-market sale | 1,915 disposed | 6.72 | 12,868.80 | Form 4, filing 0001193125-26-119707 | |
| 2025-03-26 |
Kalaris Therapeutics, Inc. KLRS |
S, Open-market sale | 907 disposed | 8.97 | 8,135.16 | Form 4, filing 0000950170-25-046263 | |
| 2025-02-21 |
Allovir, Inc. ALVR |
S, Open-market sale | 96 disposed | 10.08 | 967.28 | Form 4, filing 0000950170-25-025633 | |
| 2025-01-23 |
Allovir, Inc. ALVR |
S, Open-market sale | 32 disposed | 9.45 | 302.52 | Form 4, filing 0000950170-25-009204 | |
| 2025-01-23 |
Allovir, Inc. ALVR |
S, Open-market sale | 4 disposed | 9.94 | 39.76 | Form 4, filing 0000950170-25-009204 | |
| 2025-01-10 |
Allovir, Inc. ALVR |
S, Open-market sale | 332 disposed | 0.44 | 146.11 | Form 4, filing 0000950170-25-004833 | |
| 2024-11-19 |
Allovir, Inc. ALVR |
S, Open-market sale | 554 disposed | 0.55 | 303.87 | Form 4, filing 0000950170-24-129263 | |
| 2024-11-05 |
Allovir, Inc. ALVR |
S, Open-market sale | 1,655 disposed | 0.86 | 1,431.41 | Form 4, filing 0000950170-24-122334 | |
| 2024-10-22 |
Allovir, Inc. ALVR |
S, Open-market sale | 486 disposed | 0.77 | 373.15 | Form 4, filing 0000950170-24-116646 | |
| 2024-10-21 |
Allovir, Inc. ALVR |
S, Open-market sale | 479 disposed | 0.78 | 373.14 | Form 4, filing 0000950170-24-116646 | |
| 2024-10-03 |
Allovir, Inc. ALVR |
S, Open-market sale | 301 disposed | 0.81 | 245.25 | Form 4, filing 0000950170-24-112911 | |
| 2024-08-19 |
Allovir, Inc. ALVR |
S, Open-market sale | 544 disposed | 0.76 | 413.17 | Form 4, filing 0000950170-24-099104 | |
| 2024-08-05 |
Allovir, Inc. ALVR |
S, Open-market sale | 1,692 disposed | 0.73 | 1,243.28 | Form 4, filing 0000950170-24-092806 | |
| 2024-07-22 |
Allovir, Inc. ALVR |
S, Open-market sale | 481 disposed | 0.74 | 355.56 | Form 4, filing 0000950170-24-085670 | |
| 2024-07-19 |
Allovir, Inc. ALVR |
S, Open-market sale | 479 disposed | 0.75 | 359.30 | Form 4, filing 0000950170-24-085670 | |
| 2024-07-02 |
Allovir, Inc. ALVR |
S, Open-market sale | 304 disposed | 0.72 | 218.88 | Form 4, filing 0000950170-24-081515 | |
| 2024-05-17 |
Allovir, Inc. ALVR |
S, Open-market sale | 541 disposed | 0.75 | 405.37 | Form 4, filing 0000950170-24-062983 | |
| 2024-05-03 |
Allovir, Inc. ALVR |
S, Open-market sale | 1,597 disposed | 0.80 | 1,271.21 | Form 4, filing 0000950170-24-054510 | |
| 2024-04-22 |
Allovir, Inc. ALVR |
S, Open-market sale | 480 disposed | 0.75 | 360.00 | Form 4, filing 0000950170-24-046906 | |
| 2024-04-19 |
Allovir, Inc. ALVR |
S, Open-market sale | 473 disposed | 0.75 | 355.03 | Form 4, filing 0000950170-24-046906 | |
| 2024-04-02 |
Allovir, Inc. ALVR |
S, Open-market sale | 281 disposed | 0.77 | 216.93 | Form 4, filing 0000950170-24-041811 | |
| 2024-02-20 |
Allovir, Inc. ALVR |
S, Open-market sale | 494 disposed | 0.70 | 343.43 | Form 4, filing 0000950170-24-018780 | |
| 2024-02-08 |
Allovir, Inc. ALVR |
S, Open-market sale | 11,150 disposed | 0.67 | 7,493.92 | Form 4, filing 0000950170-24-013491 | |
| 2024-02-05 |
Allovir, Inc. ALVR |
S, Open-market sale | 5,792 disposed | 0.67 | 3,880.64 | Form 4, filing 0000950170-24-011770 | |
| 2024-01-23 |
Allovir, Inc. ALVR |
S, Open-market sale | 901 disposed | 0.67 | 604.39 | Form 4, filing 0000950170-24-007404 | |
| 2024-01-04 |
Allovir, Inc. ALVR |
S, Open-market sale | 310 disposed | 0.64 | 198.09 | Form 4, filing 0000950170-24-002934 | |
| 2023-12-27 |
Allovir, Inc. ALVR |
S, Open-market sale | 28,335 disposed | 0.74 | 20,837.56 | Form 4, filing 0000950170-24-000428 | |
| 2023-11-17 |
Allovir, Inc. ALVR |
S, Open-market sale | 403 disposed | 1.63 | 657.33 | Form 4, filing 0001209191-23-056320 | |
| 2023-10-20 |
Allovir, Inc. ALVR |
S, Open-market sale | 357 disposed | 1.54 | 550.14 | Form 4, filing 0001209191-23-053347 | |
| 2023-10-19 |
Allovir, Inc. ALVR |
S, Open-market sale | 358 disposed | 1.58 | 565.64 | Form 4, filing 0001209191-23-053347 | |
| 2023-10-03 |
Allovir, Inc. ALVR |
S, Open-market sale | 222 disposed | 1.98 | 438.74 | Form 4, filing 0001209191-23-052227 | |
| 2023-08-17 |
Allovir, Inc. ALVR |
S, Open-market sale | 1,653 disposed | 2.50 | 4,125.06 | Form 4, filing 0001209191-23-046731 | |
| 2023-07-20 |
Allovir, Inc. ALVR |
S, Open-market sale | 342 disposed | 3.35 | 1,144.81 | Form 4, filing 0001209191-23-043120 | |
| 2023-07-19 |
Allovir, Inc. ALVR |
S, Open-market sale | 342 disposed | 3.56 | 1,218.03 | Form 4, filing 0001209191-23-043120 | |
| 2023-06-09 |
Allovir, Inc. ALVR |
S, Open-market sale | 5,045 disposed | 5.64 | 28,452.79 | Form 4, filing 0001209191-23-036796 | |
| 2023-04-20 |
Allovir, Inc. ALVR |
S, Open-market sale | 349 disposed | 3.63 | 1,265.30 | Form 4, filing 0001209191-23-025116 | |
| 2023-04-19 |
Allovir, Inc. ALVR |
S, Open-market sale | 348 disposed | 3.71 | 1,290.63 | Form 4, filing 0001209191-23-025116 | |
| 2023-01-20 |
Allovir, Inc. ALVR |
S, Open-market sale | 338 disposed | 5.14 | 1,738.60 | Form 4, filing 0001209191-23-004500 | |
| 2023-01-19 |
Allovir, Inc. ALVR |
S, Open-market sale | 1,557 disposed | 5.08 | 7,905.98 | Form 4, filing 0001209191-23-004500 | |
| 2022-11-11 |
Allovir, Inc. ALVR |
S, Open-market sale | 18,011 disposed | 8.18 | 147,257.94 | Form 4, filing 0000899243-22-035701 | |
| 2022-11-10 |
Allovir, Inc. ALVR |
S, Open-market sale | 5,989 disposed | 8.00 | 47,924.58 | Form 4, filing 0000899243-22-035701 | |
| 2022-10-24 |
Allovir, Inc. ALVR |
S, Open-market sale | 2,000 disposed | 8.13 | 16,269.00 | Form 4, filing 0000899243-22-034057 | |
| 2022-10-21 |
Allovir, Inc. ALVR |
S, Open-market sale | 11,334 disposed | 8.45 | 95,799.50 | Form 4, filing 0000899243-22-034057 | |
| 2022-10-20 |
Allovir, Inc. ALVR |
S, Open-market sale | 345 disposed | 9.36 | 3,229.44 | Form 4, filing 0000899243-22-034263 | |
| 2022-10-19 |
Allovir, Inc. ALVR |
S, Open-market sale | 345 disposed | 9.36 | 3,229.44 | Form 4, filing 0000899243-22-034057 | |
| 2022-04-20 |
Allovir, Inc. ALVR |
S, Open-market sale | 276 disposed | 6.68 | 1,844.87 | Form 4, filing 0000899243-22-015390 | |
| 2022-01-20 |
Allovir, Inc. ALVR |
S, Open-market sale | 1,563 disposed | 8.75 | 13,680.31 | Form 4, filing 0000899243-22-003003 | |
| 2021-02-22 |
Allovir, Inc. ALVR |
S, Open-market sale | 800 disposed | 43.14 | 34,509.04 | Form 4, filing 0001209191-21-013482 | |
| 2021-02-18 |
Allovir, Inc. ALVR |
S, Open-market sale | 541 disposed | 40.39 | 21,852.67 | Form 4, filing 0000899243-21-007335 | |
| 2021-02-18 |
Allovir, Inc. ALVR |
S, Open-market sale | 200 disposed | 39.36 | 7,871.00 | Form 4, filing 0000899243-21-007335 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 56
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Hagen Brett R, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001681782
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6